As of May 05, 2026, CRISPR Therapeutics AG's top three insider holders are Simeon George (Director, 2.04Mn shares), Rodger Novak (President, 573.01K shares), Bradley J Phd Bolzon (Director, 148.83K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Simeon George | - | 0 | 2,038,763 | 17 Jul, 2025 |
| Rodger Novak | President | 573,007 | 0 | 01 Jul, 2021 |
| Bradley J Phd Bolzon | - | 0 | 148,831 | 21 Jul, 2021 |
| James R. Kasinger | General Counsel And Secretary | 94,308 | 0 | 24 Mar, 2026 |
| Tony W Ho | Executive Vp, Head Of Rd | 52,364 | 0 | 07 Dec, 2021 |
| Douglas A Treco | - | 22,000 | 0 | 08 Aug, 2025 |
| Raju Prasad | Chief Financial Officer | 15,565 | 0 | 24 Mar, 2026 |
| Naimish Patel | Chief Medical Officer | 13,143 | 0 | 17 Mar, 2026 |
| Julianne Bruno | Chief Operating Officer | 10,544 | 0 | 24 Mar, 2025 |
| Brendan Smith | Chief Financial Officer | 5,072 | 0 | 22 Feb, 2023 |
| Phuong Khanh Morrow | Chief Medical Officer | 4,411 | 0 | 25 May, 2023 |
| Michael John Tomsicek | Chief Financial Officer | 1,891 | 0 | 10 Aug, 2021 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 20 Mar, 2026 | Raju Prasad | Common Shares | A | 6,250 | - | 19,273 | D | M |
| 20 Mar, 2026 | James R. Kasinger | Common Shares | A | 6,250 | - | 97,490 | D | M |
| 20 Mar, 2026 | Naimish Patel | Stock Option (Right to Buy) | A | 38,499 | $0.00 | 38,499 | D | A |
| 23 Mar, 2026 | James R. Kasinger | Common Shares | D | 3,182 | $46.78 | 94,308 | D | S |
| 20 Mar, 2026 | Naimish Patel | Restricted Stock Units | A | 30,000 | $0.00 | 30,000 | D | A |
| 23 Mar, 2026 | Raju Prasad | Common Shares | D | 3,708 | $46.78 | 15,565 | D | S |
| 20 Mar, 2026 | James R. Kasinger | Stock Option (Right to Buy) | A | 38,499 | $0.00 | 38,499 | D | A |
| 20 Mar, 2026 | Raju Prasad | Stock Option (Right to Buy) | A | 38,499 | $0.00 | 38,499 | D | A |
| 20 Mar, 2026 | Raju Prasad | Restricted Stock Units | A | 27,500 | $0.00 | 27,500 | D | A |
| 20 Mar, 2026 | James R. Kasinger | Restricted Stock Units | A | 25,000 | $0.00 | 25,000 | D | A |
| 20 Mar, 2026 | James R. Kasinger | Restricted Stock Units | D | 6,250 | - | 12,000 | D | M |
| 20 Mar, 2026 | Raju Prasad | Restricted Stock Units | D | 6,250 | - | 12,500 | D | M |
| 14 Mar, 2026 | James R. Kasinger | Common Shares | A | 6,875 | - | 94,690 | D | M |
| 14 Mar, 2026 | Raju Prasad | Common Shares | A | 10,000 | - | 16,767 | D | M |
| 14 Mar, 2026 | Naimish Patel | Common Shares | A | 8,125 | - | 16,293 | D | M |
| 14 Mar, 2026 | Raju Prasad | Common Shares | A | 6,875 | - | 23,642 | D | M |
| 16 Mar, 2026 | Naimish Patel | Common Shares | D | 3,150 | $48.26 | 13,143 | D | S |
| 16 Mar, 2026 | James R. Kasinger | Common Shares | D | 3,450 | $48.26 | 91,240 | D | S |
| 14 Mar, 2026 | Naimish Patel | Restricted Stock Units | D | 8,125 | - | 24,375 | D | M |
| 14 Mar, 2026 | James R. Kasinger | Restricted Stock Units | D | 6,875 | - | 20,625 | D | M |